Clinic
Planned Parenthood of Central and Western New York, INC
Planned Parenthood of Central and Western New York, INC was paid $20.80M by Medicaid between Jan 2018 and Dec 2024, across 59 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 17% of everything it billed.
33Billing provider infoPLANNED PARENTHOOD OF CENTRAL AND WESTERN NEW YORK, INC
ROCHESTER, NY 14605
ROCHESTER, NY 14605
33aNPI1306909957assigned 12/18/2006
33bProvider typeAmbulatory Family Planning Facility
28Total paid$20.80M
24GClaims363,810
24DCodes billed59
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Ambulatory Family Planning Facility providers in New York
Rank by total paid#3 of 7
Median peer was paid$9.13M
This provider vs. median2.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 25,658 | $1.27M | |
| 2019 | 45,114 | $2.48M | |
| 2020 | 50,527 | $2.96M | |
| 2021 | 62,464 | $3.40M | |
| 2022 | 66,560 | $3.66M | |
| 2023 | 66,472 | $3.89M | |
| 2024incomplete | 47,015 | $3.15M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 17% | 35,571 | 25,995 | $3.56M |
| 59840 | 14% | 4,897 | 4,885 | $2.92M | |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 13% | 26,937 | 20,486 | $2.79M |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 8.3% | 16,506 | 15,909 | $1.72M |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 4.1% | 27,955 | 27,328 | $846K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 3.6% | 8,637 | 5,577 | $745K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.5% | 5,719 | 4,666 | $719K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3.4% | 4,795 | 4,716 | $706K |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 3.4% | 1,552 | 1,541 | $702K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.2% | 4,720 | 4,487 | $665K |
| S0190 | Mifepristone, oral, 200 mg | 3.0% | 11,608 | 11,580 | $631K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 2.4% | 15,759 | 15,397 | $501K |
47 more codes
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.4% | 28,033 | $498K |
| 11981 | 2.3% | 1,798 | $477K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 1.9% | 3,973 | $401K |
| 11982 | 1.8% | 1,376 | $380K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 1.8% | 16,994 | $368K |
| 76830 | Ultrasound, transvaginal | 1.4% | 3,807 | $292K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.3% | 20,226 | $266K |
| 58300 | 1.3% | 1,923 | $266K | |
| 99201 | 1.2% | 3,530 | $240K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 1,623 | $194K |
| 81025 | <1% | 35,183 | $154K | |
| 58301 | <1% | 930 | $128K | |
| 86703 | <1% | 8,602 | $128K | |
| J7297 | Levonorgestrel-releasing intrauterine contraceptive system (liletta), 52 mg | <1% | 647 | $116K |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | <1% | 247 | $68K |
| S0191 | Misoprostol, oral, 200 mcg | <1% | 12,505 | $45K |
| 36415 | Collection of venous blood by venipuncture | <1% | 6,263 | $37K |
| 88141 | <1% | 1,582 | $32K | |
| 88142 | <1% | 1,362 | $29K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 897 | $29K |
| J2788 | Injection, rho d immune globulin, human, minidose, 50 micrograms (250 i.u.) | <1% | 839 | $25K |
| J7300 | Intrauterine copper contraceptive (paragard) | <1% | 66 | $24K |
| S4993 | Contraceptive pills for birth control | <1% | 2,539 | $23K |
| 86901 | <1% | 307 | $11K | |
| 85018 | <1% | 13,066 | $11K | |
| 99051 | <1% | 965 | $10K | |
| 87210 | <1% | 8,290 | $9K | |
| 99385 | <1% | 65 | $8K | |
| 83986 | <1% | 7,877 | $5K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 207 | $5K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 13 | $5K |
| 99441 | <1% | 13 | $2K | |
| 84403 | <1% | 222 | $2K | |
| 84702 | <1% | 976 | $1K | |
| 86803 | <1% | 2,383 | $993.05 | |
| 86780 | <1% | 2,779 | $896.07 | |
| 96127 | <1% | 1,996 | $629.84 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 231 | $534.58 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 554 | $404.55 |
| 81002 | <1% | 2,374 | $386.64 | |
| 82670 | <1% | 54 | $328.96 | |
| S5001 | Prescription drug, brand name | <1% | 389 | $290.00 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,136 | $193.05 |
| 82565 | <1% | 88 | $54.39 | |
| 84132 | <1% | 74 | $47.18 | |
| 87088 | 0% | 66 | $0.00 | |
| S5000 | Prescription drug, generic | 0% | 84 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialOLECK, CHRISTIAN (VP/CFO ACTING CEO)
| Provider | Location | Paid |
|---|---|---|
| Planned Parenthood of the North Country New York, INC. | Watertown, NY | $3.95M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.